Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Condylomata Acuminata 2 Warts 1 Prostatic Neoplasms 1 Keratosis, Actinic 1 High-grade Anal Intraepithelial Neoplasia 1 Carcinoma, Basal Cell 1

Interventions

3-ingenyl angelate 37 Aminolevulinic Acid 33 Imiquimod 25 Photochemotherapy 22 Fluorouracil 22 methyl 5-aminolevulinate 12 Gels 12 Cryotherapy 12 Diclofenac 11 tirbanibulin 6 Solutions 6 BF-200 ALA 6 calcipotriene 5 Petrolatum 5 Ointments 5 LEO 43204 5 Radiotherapy 4 Prilocaine 4 Lidocaine 4 Therapeutics 3 Niacinamide 3 Cryosurgery 3 1-phenyl-3,3-dimethyltriazene 3 SR-T100 2 Phototherapy 2 Imipramine 2 Deoxyribonuclease (Pyrimidine Dimer) 2 Celecoxib 2 Blue Light 2 Biopsy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Keratosis, Actinic × green tea extract polyphenone E × Clear all

NCT07137819 2025-08-22

EXACT-1

Aresus Pharma GmbH

Phase 3 Recruiting

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡